The role of tubular injury in diabetic nephropathy

European Journal of Internal Medicine

Volumn 20, Issue 6, 2009, Pages 551-555

  Magri, Caroline Jane ^a   Fava, Stephen ^a  

^a MATER DEI HOSPITAL   (Malta)

Author keywords

Advanced glycation end products; Diabetes mellitus; Diabetic nephropathy; Proteinuria; Tubule

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALBUMIN; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; C PEPTIDE; COLLAGEN TYPE 4; FIBRONECTIN; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; ORNITHINE DECARBOXYLASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLATELET DERIVED GROWTH FACTOR; RANTES; SCATTER FACTOR; SOMATOMEDIN C; TRANSCRIPTION FACTOR AP 1; TRANSFERRIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; CELL HYPOXIA; DIABETIC NEPHROPATHY; GLOMERULUS FILTRATION RATE; HUMAN; HYPERGLYCEMIA; KIDNEY FAILURE; KIDNEY HYPERTROPHY; KIDNEY TUBULE DAMAGE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; HUMANS; KIDNEY DISEASES; KIDNEY TUBULES; PROTEINURIA;

EID: 70349266458     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2008.12.012     Document Type: Review

References (78)

1. Pavers A.C. Diabetes mellitus. In: Braunwald E., Fauci A.S., Isselbacher K.J., et al. (Eds). Harrison online (2002), The McGraw-Hill Companion, New York
2. Parving H.-H., Osterby R., and Ritz E. Diabetic nephropathy. In: Brenner B.M. (Ed). The kidney (2000), W B Saunders, Philadelphia 1731-1773
3. Bader R., Bader H., Grund K.E., Mackensen-Haen S., Christ H., and Bohle A. Structure and function of the kidney in diabetic glomerulosclerosis: correlations between morphological and functional parameters. Pathol Res Pract 167 (1980) 204-216
4. Marcussen N. Atubular glomeruli and the structural basis for chronic renal failure. Lab Invest 66 (1992) 265-284
5. Taft J.L., Nolan C.J., Yeung S.P., Hewitson T.D., and Martin F.I. Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria. Diabetes 43 (1994) 1046-1051
6. Gilbert R.E., and Cooper M.E. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?. Kidney Int 56 (1999) 1627-1637
7. Ginevri F., Piccotti E., Alinovi R., et al. Reversible tubular proteinuria precedes microalbuminuria and correlates with the metabolic status in diabetic children. Pediatr Nephrol 7 1 (Feb 1993) 23-26
8. Suzuki K., Babazono T., Murata H., and Iwamoto Y. Clinical significance of urinary liver-type fatty acid-binding protein in patients with diabetic nephropathy. Diabetes Care 28 (2005) 2038-2039
9. Kamijo A., Kimura K., Sugaya T., et al. Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. J Lab Clin Med 143 (2004) 23-30
10. Nakamura T., Sugaya T., Kawagoe Y., Ueda Y., Osada S., and Koide H. Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy. Diabetes Care 28 (2005) 2728-2732
11. Cabré A., Lázaro I., Girona J., et al. Plasma fatty acid-binding protein 4 increases with renal dysfunction in type 2 diabetic patients without microalbuminuria. Clin Chem. 54 1 (Jan 2008) 181-187 [Electronic Publication 2007 Nov 16]
12. Thomas M.C., Burns W.C., and Cooper M.E. Tubular changes in early diabetic nephropathy. Adv Chronic Kidney Dis 12 (2005) 177-186
13. Vallon V., Blantz R.C., and Thomson S. Glomerular hyperfiltration and the salt paradox in early type 1 diabetes mellitus: a tubulo-centric view. J Am Soc Nephrol 14 (2003) 530-537
14. Tucker B.J., Collins R.C., Ziegler M.G., and Blantz R.C. Disassociation between glomerular hyperfiltration and extracellular volume in diabetic rats. Kidney Int 39 (1991) 1176-1183
15. Hostetter T.H., Troy J.L., and Brenner B.M. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19 (1981) 410-415
16. O'Bryan G.T., and Hostetter T.H. The renal hemodynamic basis of diabetic nephropathy. Semin Nephrol 17 (1997) 93-100
17. Rasch R., and Norgaard J.O. Renal enlargement: comparative autoradiographic studies of 3H-thymidine uptake in diabetic and uninephrectomized rats. Diabetologia 25 (1983) 280-287
18. Seyer-Hansen K., Hansen J., and Gundersen H.J. Renal hypertrophy in experimental diabetes. A morphometric study. Diabetologia 18 (1980) 501-505
19. Rasch R., and Dørup J. Quantitative morphology of the rat kidney during diabetes mellitus and insulin treatment. Diabetologia 40 (1997) 802-809
20. Thomson S.C., Vallon V., and Blantz R.C. Kidney function in early diabetes: the tubular hypothesis of glomerular filtration. Am J Physiol 286 1 (2004) F8-F15
21. O'Hagan M., Howey J., and Greene S.A. Increased proximal tubular reabsorption of sodium in childhood diabetes mellitus. Diabet Med 8 (1991) 44-48
22. Mbanya J.C., Thomas T.H., Taylor R., Alberti K.G., and Wilkinson R. Increased proximal tubular sodium reabsorption in hypertensive patients with type 2 diabetes. Diabet Med 6 (1989) 614-620
23. Vallon V., Richter K., Blantz R.C., Thomson S., and Osswald H. Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J Am Soc Nephrol 10 (1999) 2569-2576
24. Vestri S., Okamoto M.M., de Freitas H.S., et al. Changes in sodium or glucose filtration rate modulate expression of glucose transporters in renal proximal tubular cells of rat. J Membr Biol 182 (2001) 105-112
25. Thomson S.C., Deng A., Bao D., Satriano J., Blantz R.C., and Vallon V. Ornithine decarboxylase, kidney size and tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J Clin Invest 107 (2001) 161-162
26. Deng A., Munger K.A., Valdivielso J.M., et al. Increased expression of ornithine decarboxylase in distal tubules of early diabetic rat kidneys: are polyamines paracrine hypertrophic factors?. Diabetes 52 5 (May 2003) 1235-1239
27. Saad S., Stevens V.A., Wassef L., et al. High glucose transactivates the EGF receptor and up-regulates serum glucocorticoid kinase in the proximal tubule. Kidney Int 68 3 (Sep 2005) 985-997
28. Vervoort G., Veldman B., Berden J.H.M., Smits P., and Wetzels J.F.M. Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion. Eur J Clin Invest 35 5 (May 2005) 330-336
29. Zerbini G., Bonfanti R., Meschi F., et al. Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes. Diabetes 55 9 (Sep 2006) 2620-2625
30. Rebsomen L., Pitel S., Boubred F., et al. C-peptide replacement improves weight gain and renal function in diabetic rats. Diabetes & Metabolism 32 3 (2006) 223-228
31. Rebsomen l., Khammar A., Raccah D., and Tsimaratos M. C-peptide effects on renal physiology and diabetes. Exp Diabetes Res 2008 (2008) 281536
32. Qi W., Chen X., Zhang Y., et al. High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism. Nephrol Dial Transplant 22 11 (Nov 2007) 3147-3153
33. Tojo A., Onozato M.L., Ha H., et al. Reduced albumin reabsorption in the proximal tubule of early-stage diabetic rats. Histochem Cell Biol 116 3 (Sep 2001) 269-276
34. Sanchez-Lozada L.G., Tapia E., Johnson R.J., Rodriguez-Iturbe B., and Herrera-Acosta J. Glomerular haemodynamic changes associated with arteriolar lesions and tubulointerstitial inflammation. Kidney Int 65 (2004) 1971-1972
35. Nangaku M. Mechanisms of tubulointerstitial injury in the kidney: final common pathway to end-stage renal failure. Int Med 43 (2004) 9-17
36. Anderson S. Mechanisms of injury in progressive renal disease. Exp Nephrol 4 Suppl 1 (1996) 34-40
37. Ibrahim H.N., Rosenberg M.E., and Hostetter T.H. Proteinuria. In: Seldin D.W., and Giebisch G. (Eds). The kidney: physiology and pathophysiology. (3rd ed.) vol. II (2000), Lippincott Williams & Wilkins, Philadelphia, PA 2269-2296
38. Imai E., Nakajima H., and Kaimori J.Y. Albumin turns on a vicious spiral of oxidative stress in renal proximal tubules. Kidney Int 66 (2004) 2085-2087
39. Meyer T.W. Tubular injury in glomerular disease. Kidney Int 63 (2003) 774-787
40. Tikellis C., Johnston C.I., Forbes J.M., et al. Characterization of renal angiotensin converting enzyme 2 in diabetic nephropathy. Hypertension 41 (2003) 392-397
41. Tang S., Leung J.C., Abe K., et al. Albumin stimulates IL-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest 111 (2003) 515-527
42. Wang Y., Rangan G.K., Tay Y.C., Wang Y., and Harris D.C.H. Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor K{green}B in proximal tubule cells. J Am Soc Nephrol 10 (1999) 1204-1213
43. Arici M., Chana R., Lewington A., Brown J., and Brunskill N.J. Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-γ. J Am Soc Nephrol 14 (2003) 17-27
44. Sommer M., and Wolf G. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide. Am J Nephrol 27 4 (2007) 425-434 Electronic Publication 2007 Jul 3
45. Chung B.H., Lim S.W., Ahn K.O., et al. Protective effect of peroxisome proliferator activated receptor gamma agonistson diabetic and non-diabetic renal diseases. Nephrology (Carlton) 10 Suppl (Oct 2005) S40-43
46. Tang S., Leung J.C., Tsang A.W., Lan H.Y., Chan T.M., and Lai K.N. Transferrin up-regulates chemokine synthesis by human proximal tubular epithelial cells: implication on mechanism of tubuloglomerular communication in glomerulopathic proteinuria. Kidney Int 61 (2002) 1655-1665
47. Tang S., Lai K.N., Chan T.M., Lan H.Y., Ho S.K., and Sacks S.H. Transferrin but not albumin mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. Am J Kidney Dis 37 (2001) 94-103
48. Brooimans R.A., Stegmann A.P., van Dorp W.T., et al. Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J Clin Invest 88 (1991) 379-384
49. Hirschberg R., and Wang S. Proteinuria and growth factors in the development of tubulointerstitial injury and scarring in kidney disease. Curr Opin Nephrol Hypertens 14 (2005) 43-52
50. Wang S., and Hirschberg R. Tubular epithelial cell activation and interstitial fibrosis. The role of glomerular ultrafiltration of growth factors in the nephritic syndrome and diabetic nephropathy. Nephrol Dial Transplant 14 (1999) 2072-2074
51. Goestemeyer A.K., Marks J., Srai S.K., Debnam E.S., and Unwin R.J. GLUT2 protein at the rat proximal tubule brush border membrane correlates with protein kinase C (PKC)-betal and plasma glucose concentration. Diabetologia 50 (2007) 2209-2217
52. Phillips A.O., Steadman R., Morrisey K., Martin J., Eynstone L., and Williams J.D. Exposure of human renal proximal tubular cells to glucose leads to accumulation of type IV collagen and fibronectin by decreased degradation. Kidney Int 52 (1997) 973-984
53. Gómez-Garre D., Largo R., Tejera N., Fortes J., Manzarbeitia F., and Egido J. Activation of NF-kappaB in tubular epithelial cells of rats with intense proteinuria: role of angiotensin II and endothelin-1. Hypertension 37 4 (Apr 2001) 1171-1178
54. Schenk O., Ling H., Sebekova K., Vamvakas S., and Heidland A. High-glucose media enhance the responsiveness of tubular cells to growth promoters: effect on lysosomal cathepsins and protein degradation. Miner Electrolyte Metab 24 (1998) 254-260
55. Fioretto P., Steffes M.W., Sutherland D.E., Goetz F.C., and Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339 2 (Jul 9 1998) 69-75
56. Bohlender J.M., Franke S., Stein G., and Wolf G. Advanced glycation end products and the kidney. Am J Physiol Renal Physiol 289 (2005) F645-F659
57. Yamagishi S., Inagaki Y., Okamoto T., Amano S., Koga K., and Takeuchi M. Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells. Kidney Int 63 (2003) 464-473
58. Verbeke P., Perichon M., Friguet B., and Bakala H. Inhibition of nitric oxide synthase activity by early and advanced glycation end products in cultured rabbit proximal tubular epithelial cells. Biochim Biophys Acta 1502 3 (2000) 481-494
59. Oldfield M.D., Bach L.A., Forbes J.M., et al. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 108 12 (2001) 1853-1863
60. Li J.H., Wang W., Huang X.R., Oldfield M., Schmidt A.M., Cooper M.E., et al. Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway. Am J Pathol 164 4 (2004) 1389-1397
61. Forbes J.M., Cooper M.E., Oldfield M.D., and Thomas M.C. Role of advanced glycation end products in diabetic nephropathy. J Am Soc Nephrol 14 (2003) S254-S258
62. Miyata T., and Kurokawa K. A detective story for biomedical footprints towards new therapeutic interventions in diabetic nephropathy. Int Med 42 (2003) 1165-1171
63. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 17 (2006) 17-25
64. Fujisawa T., Ikegami H., Kawaguchi Y., et al. Meta-analysis of association of insertion/deletion polymorphism of angiotensin-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 41 (1998) 47-53
65. Tarnow L., Gluud C., and Parving H.H. Diabetic nephropathy and the insertion/ deletion polymorphism of the angiotensin-converting enzyme gene. Nephrol Dial Transplant 13 (1998) 1125-1130
66. Fava S., Azzopardi J., Ellard S., and Hattersley A.T. ACE gene polymorphism as a prognostic indicator in patients with type 2 diabetes and established renal disease. Diabetes Care 24 (2001) 2115-2120
67. Ng D.P., Tai B.C., Koh D., Tan K.W., and Chia K.S. Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Diabetologia 48 (2005) 1008-1016
68. Osicka T.M., Forbes J.M., Thallas V., Brammar G.C., Jerums G., and Comper W.D. Ramipril prevents microtubular changes in proximal tubules from streptozotocin diabetic rats. Nephrology (Carlton) 8 4 (Aug 2003) 205-211
69. Jacobsen P.K. Preventing end-stage renal disease in diabetic patients - genetic aspect (part 1). JRAAS 6 (2005) 1-14
70. Bhaskaran M., Reddy K., Radhakrishanan N., Franki N., Ding G., and Singhal P.C. Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol Renal Physiol 284 (2003) F955-F965
71. Su Z., Zimpelmann J., and Burns K.D. Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int 69 (2006) 2212-2218
72. Wong D.W., Oudit G.Y., Reich H., et al. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol 171 2 (Aug 2007) 438-451 [Electronic Publication 2007 Jun 28]
73. Ye M., Wysocki J., Naaz P., Salabat M.R., LaPointe M.S., and Batlle D. Increased ACE2 and decreased ACE production in renal tubules from diabetic mice - a renoprotective combination?. Hypertension 43 (2004) 1120-1125
74. Rocco M.V., Chen Y., Goldfarb S., and Ziyadeh F.H. Elevated glucose stimulates TGF-ß gene expression and bioactivity in proximal tubule. Kidney Int 41 (1992) 107-114
75. Donald Fraser D., Brunskill N., Ito T., and Phillips A. Long-term exposure of proximal tubular epithelial cells to glucose induces transforming growth factor-ß1 synthesis via an autocrine PDGF loop. Am J Pathol 163 (2003) 2565-2574
76. Kobayashi T., Inoue T., Okada H., et al. Connective tissue growth factor mediates the profibrotic effects of transforming growth factor-beta produced by tubular epithelial cells in response to high glucose. Clin Exp Nephrol 9 2 (2005) 114-121
77. Qi W., Chen X., Polhill T.S., Sumual S., Twigg S., Gilbert R.E., et al. TGF-beta1 induces IL-8 and MCP-1 through a connective tissue growth factor-independent pathway. Am J Physiol Renal Physiol 290 3 (2006) F703-709
78. Osicka T.M., Houlihan C.A., Chan J.G., Jerums G., and Comper W.D. Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage. Diabetes 49 (2000) 1579-1584